SLC7A11 and breast cancer: Recent studies have shown that SLC7A11 is highly expressed in several tumor types, including lung cancer, breast cancer, colorectal cancer, and melanoma, and plays a pivotal role in the immune evasion mechanisms of tumors [24, 25] (Table 1) (Fig. 1).